Barclays’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Barclays’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200,000	Closed	-$710K	–	5527
2026 Q1	$710K	Sell	200,000 -522,900	-72%	-$2.14M	﹤0.01%	2965
2025 Q4	$3.41M	Buy	+722,900	New	+$3.22M	﹤0.01%	2519
2023 Q4	–	Sell	-3,048,000	Closed	-$24.2M	–	5308
2023 Q3	$24.2M	Buy	+3,048,000	New	+$19.2M	0.02%	703

Other funds holding MSOS

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Barclays's MSOS Position: Q2 2026 in Review

Barclays held its AdvisorShares Pure US Cannabis ETF (MSOS) position steady in Q2 2026 at 2,000 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4693.

Barclays first reported a position in MSOS in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.91M in Q1 2022. 168 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

Barclays held 2,000 shares of AdvisorShares Pure US Cannabis ETF worth $10.2K as of Q2 2026.
Barclays left its AdvisorShares Pure US Cannabis ETF share count unchanged in Q2 2026.
AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4693 holding.
Barclays first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2022 and has held it in 18 quarters since.
Barclays's AdvisorShares Pure US Cannabis ETF position peaked at $1.91M in Q1 2022.
168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.